# Clinical Cases: Atypical Bacteria

## Case 1: Rocky Mountain Spotted Fever

### Presentation
A 12-year-old boy from North Carolina is brought to the emergency department in mid-July with 4 days of high fever, severe headache, and body aches. His parents report that he was camping 10 days ago but do not recall seeing any tick bites. Today they noticed a rash that started on his wrists and ankles and is now spreading to his arms, legs, and trunk. On examination, temperature is 39.8°C, heart rate 115 bpm. The child appears ill with a petechial rash most prominent on the extremities, including palms and soles. Laboratory studies show sodium 128 mEq/L and platelets 95,000/μL.

### Clinical Image
![RMSF rash on extremities](image_01.png)
*Petechial rash of Rocky Mountain spotted fever involving the palms and soles, with characteristic peripheral-to-central spread pattern.*

**Image Source**: Lecture image - Rickettsia rickettsii infection

### Questions

1. **What is the most likely diagnosis, and what is the causative organism?**

2. **Why is immediate empiric treatment critical even without laboratory confirmation?**

3. **Explain the pathophysiologic basis for the clinical findings.**

4. **What is the appropriate treatment, even in pediatric patients?**

### Answers

1. **Diagnosis and organism**: This is **Rocky Mountain spotted fever (RMSF)** caused by **Rickettsia rickettsii**, transmitted by dog ticks (Dermacentor species). Despite its name, most cases occur in the southeastern and south-central United States. The classic triad is fever, headache, and rash, with the rash characteristically beginning on the wrists and ankles (peripherally) and spreading centrally. The presentation in summer, geographic location, and rash distribution are classic.

2. **Critical need for empiric treatment**: RMSF has a **mortality rate of 20-25% if untreated**, with death occurring within 8-15 days of symptom onset. Delays in treatment significantly increase mortality. Serologic confirmation (IFA antibodies) is not detectable until the second week of illness - **too late to guide treatment decisions**. Therefore, the diagnosis is fundamentally clinical, and **empiric treatment must begin immediately** upon clinical suspicion without waiting for laboratory confirmation.

3. **Pathophysiologic basis of findings**: R. rickettsii is an obligate intracellular pathogen that targets **vascular endothelial cells**. The resulting **vasculitis** causes:
   - **Petechial rash**: Endothelial damage leads to vascular leakage and hemorrhage
   - **Hyponatremia**: Increased vascular permeability and third-spacing of fluids
   - **Thrombocytopenia**: Platelet consumption from endothelial injury
   - **Headache**: Cerebral vasculitis
   - Can progress to DIC, ARDS, and multiorgan failure

4. **Appropriate treatment**: The treatment of choice is **doxycycline**, regardless of patient age. While tetracyclines are generally avoided in children due to dental staining, the **risk of death from untreated RMSF far outweighs the minimal risk** from a short course of doxycycline. The American Academy of Pediatrics endorses doxycycline for suspected RMSF in children. Treatment should continue for at least 3 days after defervescence or minimum 5-7 days total. Chloramphenicol is an inferior alternative due to associated risks including aplastic anemia.

---

## Case 2: Primary Syphilis

### Presentation
A 28-year-old man presents to a sexual health clinic with a painless sore on his penis that appeared about 2 weeks ago. He reports unprotected sexual contact with multiple male partners in the past 2 months. Examination reveals a single, round ulcer approximately 1.5 cm in diameter on the penile shaft with raised, indurated edges and a clean base. The lesion is non-tender. Bilateral inguinal lymph nodes are palpable but non-tender. He has no other symptoms.

### Clinical Image
![Primary syphilis chancre](image_02.png)
*Primary syphilis chancre - a painless ulcer with indurated (firm) edges and a clean base, the hallmark of primary syphilis.*

**Image Source**: Lecture image - Treponema pallidum infection

### Questions

1. **What is the diagnosis, and what organism causes this disease?**

2. **How does this lesion differ from other causes of genital ulcers?**

3. **What serologic tests should be ordered, and how are they interpreted?**

4. **What is the appropriate treatment, and what follow-up is required?**

### Answers

1. **Diagnosis and organism**: This is **primary syphilis**, the first stage of infection caused by **Treponema pallidum**, a spirochete. The chancre is the hallmark of primary syphilis, appearing 10-90 days (average 21 days) after exposure at the site of inoculation. T. pallidum cannot be cultured in vitro, making the diagnosis dependent on clinical recognition and serology.

2. **Differentiation from other genital ulcers**:
   - **Syphilis chancre**: Painless, single ulcer with indurated edges and clean base, non-tender lymphadenopathy
   - **Herpes simplex**: Painful, multiple vesicles/ulcers, tender lymphadenopathy
   - **Chancroid** (H. ducreyi): Painful ulcer with ragged undermined edges and purulent base, tender/suppurative lymph nodes
   - **Lymphogranuloma venereum**: Small, often-unnoticed primary lesion followed by prominent lymphadenopathy

3. **Serologic testing**: A **two-tier algorithm** is used:
   - **Non-treponemal tests** (RPR, VDRL): Detect antibodies to cardiolipin; become positive 1-4 weeks after chancre appears; titers correlate with disease activity and decline after treatment
   - **Treponemal tests** (FTA-ABS, TP-PA): Detect antibodies to T. pallidum antigens; confirm reactive non-treponemal tests; remain positive for life regardless of treatment

   In primary syphilis, serologic tests may still be negative (window period), so dark-field microscopy of lesion fluid can provide immediate diagnosis if available. Testing for HIV is essential given shared risk factors.

4. **Treatment and follow-up**:
   - **Treatment**: Single dose of **benzathine penicillin G 2.4 million units IM** is curative for primary syphilis
   - For penicillin-allergic non-pregnant patients: Doxycycline 100 mg twice daily for 14 days
   - **Follow-up**: Clinical and serologic (RPR/VDRL titers) at 6 and 12 months; titers should decline 4-fold by 6-12 months indicating adequate treatment
   - **Partner notification** and treatment is essential
   - The chancre heals spontaneously in 3-6 weeks regardless of treatment, but without treatment the infection progresses to secondary and tertiary stages

---

## Case 3: Chlamydial Urethritis and Reactive Arthritis

### Presentation
A 25-year-old man presents with dysuria and urethral discharge for 1 week. He also reports pain and swelling in his left knee and right heel for the past 3 days, along with eye redness. He had unprotected intercourse with a new partner 3 weeks ago. Examination reveals mucopurulent urethral discharge, a swollen left knee with effusion, Achilles tendinitis on the right, and bilateral conjunctival injection. Gram stain of urethral discharge shows numerous neutrophils but no organisms.

### Clinical Image
![Conjunctivitis and urethral discharge in reactive arthritis](image_03.png)
*Clinical findings in reactive arthritis triggered by Chlamydia trachomatis: mucopurulent urethral discharge (urethritis) and conjunctival injection (conjunctivitis), along with arthritis - formerly called Reiter syndrome.*

**Image Source**: Lecture image - Chlamydia trachomatis clinical syndromes

### Questions

1. **What is the likely diagnosis, and what organism is most likely responsible for the triggering infection?**

2. **Why does the Gram stain show neutrophils but no organisms?**

3. **What is the pathophysiology of the joint and eye manifestations?**

4. **What is the appropriate management of this patient?**

### Answers

1. **Diagnosis and triggering organism**: This patient has **reactive arthritis** (formerly Reiter syndrome) triggered by **Chlamydia trachomatis** urethritis. The classic triad is: "can't see, can't pee, can't climb a tree" - **conjunctivitis, urethritis, and arthritis**. The antecedent genitourinary infection with mucopurulent discharge (non-gonococcal urethritis) and the temporal relationship with joint symptoms support this diagnosis. Reactive arthritis can also follow enteric infections (Salmonella, Shigella, Campylobacter, Yersinia).

2. **Gram stain findings**: Chlamydia trachomatis cannot be visualized on Gram stain for several reasons: the organisms are **too small** (0.2-0.4 μm), they are **obligate intracellular pathogens** and thus not present extracellularly in discharge, and they have minimal peptidoglycan and do not retain Gram stain. The finding of neutrophils without visible organisms is characteristic of non-gonococcal urethritis (NGU) and should prompt testing for Chlamydia (and Mycoplasma genitalium).

3. **Pathophysiology of extragenital manifestations**: Reactive arthritis is an **immune-mediated inflammatory response** to infection, not direct infection of the joints or eyes. There is a strong association with **HLA-B27** antigen. The mechanism likely involves:
   - Molecular mimicry between bacterial antigens and host tissues
   - Chlamydial persistence in joint tissue (controversial)
   - Dysregulated immune response in genetically susceptible individuals

   The arthritis is typically asymmetric, oligoarticular, and preferentially affects lower extremities. Enthesitis (inflammation where tendons insert into bone, such as Achilles) is characteristic.

4. **Management**:
   - **Treat the Chlamydia infection**: Azithromycin 1g single dose or doxycycline 100 mg twice daily for 7 days
   - **Partner treatment** is essential to prevent reinfection
   - **Symptomatic treatment of arthritis**: NSAIDs are first-line
   - Severe or persistent cases may require **DMARDs** (sulfasalazine) or **TNF inhibitors**
   - Conjunctivitis is usually self-limited; if severe, ophthalmology evaluation
   - Test for other STIs including HIV
   - **Most cases resolve within 6-12 months**, but chronic or recurrent arthritis occurs in approximately 15-30% of patients